🔗 Share this article

Chancellor Reeves has revealed she is planning "specific action to address household expense challenges" in the forthcoming financial statement.

During an interview with media outlets, she emphasized that curbing inflation is a collective task of both the administration and the central bank.

The United Kingdom's price growth is projected to be the highest among the Group of Seven advanced economies this year and next.

Potential Energy Cost Measures

Reports indicate the government could intervene to bring down energy bills, for instance by reducing the current 5% level of value-added tax charged on energy.

Another option is to cut some of the policy costs currently included in household expenses.

Budgetary Limitations and Expert Predictions

The government will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for these actions.

The view from the majority of analysts is that the Chancellor will have to announce tax rises or expenditure reductions in order to adhere to her declared fiscal targets.

Previously on the same day, analysis indicated there was a £22 billion gap for the chancellor to fill, which is at the lower end of expectations.

"There's a collective job between the Bank of England and the administration to continue tackling some of the sources of inflation," the Chancellor stated to the BBC in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Pledges and International Issues

While much of the focus has been on expected tax increases, the Treasury chief said the latest data from the OBR had not changed her pledge to campaign commitments not to increase rates on earnings tax, VAT or social security contributions.

She blamed an "unpredictable world" with growing geopolitical and commercial concerns for the Budget revenue measures, likely to be directed on those "most able to pay."

International Economic Disputes

Commenting on concerns about the United Kingdom's commercial links with the Asian nation she said: "Our national security always are paramount."

Recent announcement by China to increase export controls on critical minerals and other materials that are key for high-technology manufacturing led American leader Donald Trump to propose an extra 100% tariff on goods from China, raising the prospect of an full-scale trade war between the two economic giants.

The US Treasury Secretary called the Chinese decision "economic coercion" and "a international production control attempt."

Questioned on considering the US offer to join its battle with China, Reeves said she was "very concerned" by China's measures and called on the Chinese government "to avoid restrictions and limit trade."

She said the move was "bad for the world economy and creates further challenges."

"In my view there are sectors where we must challenge Chinese policies, but there are also significant prospects to trade with China's economy, including banking sector and other areas of the economic system. We've got to achieve that equilibrium correct."

The Treasury chief also affirmed she was working with international partners "on our own essential resources approach, so that we are less reliant."

NHS Medicine Costs and Investment

Reeves also acknowledged that the cost the NHS spends on pharmaceuticals could go up as a consequence of current discussions with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and capital.

Some of the biggest global drug companies have said recently that they are either delaying or canceling projects in the United Kingdom, with several attributing the low prices they are receiving.

Recently, the government science advisor said the cost the health service spends on drugs would need to go up to halt firms and drug research funding departing from the United Kingdom.

The Chancellor told media: "It has been observed as a result of the pricing regime, that clinical trials, innovative medicines have not been available in the UK in the way that they are in other EU nations."

"The objective is to guarantee that patients getting treatment from the National Health Service are can receive the best critical treatments in the globe. And so we are looking at this situation, and... looking to attract increased funding into the UK."